Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study

NCT03197259 — Unknown, 1000 participants, Fatih Demirkan, MD

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Turkish Chronic Lymphocytic Leukemia Study Group Registry - Multicenter Prospective Study

Registry	NCT03197259, acronym CLLTRegistry
Status	Unknown
Study type	Observational
Enrollment	1000 (Estimated)
Sponsor	Fatih Demirkan, MD (Other)
Conditions	Chronic Lymphocytic Leukemia, Del(17P)
Dates	start 2017-01-01, primary completion 2023-01-01 (estimated), completion 2026-08-01 (estimated), first posted 2017-06-23, last updated 2021-03-09
Locations	1 site in Turkey (Türkiye)

-Summary

A prospective, multicenter national observational study for patients diagnosed as chronic lymphocytic leukemia across 25 centers in Turkey

Expand all sections · Collapse all

+Detailed description

The purpose of this study is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.

+Outcome measures

Primary outcomes

First line therapy therapy protocol distrubition [36 months]: The primary objective is to describe percentage of first line therapy protocols in patients initiated on therapy for CLL in the community and academic setting

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Patients diagnosed as CLL
* 18 years or older
* Able and willing to provide the written informed consent

Exclusion Criteria:

* Younger than 18 years

+Locations (1)

Facility	City	Country	Status
Dokuz Eylum Medical Favulty	Izmir	Turkey (Türkiye)	Recruiting

+Investigators

Fatih Demirkan, Prof, Principal investigator, Dokuz Eylum Medical Faculty

My Notes

Public

To Read Reading Read